Technology
Health
Pharmaceutical

ArQule

$7.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (2.59%) Today
+$0.07 (0.93%) After Hours

Why Robinhood?

You can buy or sell ArQule and other stocks, options, ETFs, and crypto commission-free!

About

ArQule, Inc. Common Stock, also called ArQule, is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. Read More The company discovers, develops and commercializes novel small molecule drugs in areas of unmet need that will dramatically extend and improve the lives of its patients. Its proprietary pipeline includes ARQ 531, Derazantinib, Miransertib, ARQ 751 and Derazantinib products. The company was founded in 1993 and is headquartered in Burlington, MA.

Employees
36
Headquarters
Burlington, Massachusetts
Founded
1993
Market Cap
821.49M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.50M
High Today
$7.93
Low Today
$7.40
Open Price
$7.40
Volume
3.35M
52 Week High
$7.93
52 Week Low
$2.23

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
Research And Development
Therapy
US
North America

News

BenzingaMay 22

ArQule, Inc., - The Tech Trader's 3 Stocks On The Move

Three stocks that had been digesting recent gains now appear to be on the rise again. ArQule, Inc. (NASDAQ: ARQL) gained 42 cents to $7.17 on 2.6 million shares Tuesday. The move, on more than 1/2 times its average volume, came on no news from the biopharmaceutical company. The stock broke out of a month-long wedge pattern last week and backed off before Tuesday's move. It edged above resistance at the July high of $7.21 intraday. A follow-through could get it to $8.50 next. Qudian Inc. (NYSE: QD) jumped ...

178
Simply Wall StMay 2

ArQule, Inc. (NASDAQ:ARQL) Insiders Increased Their Holdings

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So shareholders might well want to know whether insiders have been buying or selling shares in ArQule, Inc. (NASDAQ:ARQL). Do Insider Transactions Matter? It’s quite norma...

1,335
The Motley FoolMay 1

Arqule Inc (ARQL) Q1 2019 Earnings Call Transcript

Arqule Inc (NASDAQ:ARQL) Q1 2019 Earnings Call , 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, ladies and gentlemen and welcome to the ArQule's First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. (Operator Instructions) As a reminder, this conference maybe recorded. I would now lik...

353

Earnings

-$0.11
-$0.06
-$0.00
$0.05
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.